Call 
Do you or your loved one have nmCRPC?
nmCRPC is non-metastatic castration-resistant prostate cancer
Is ERLEADA™ right for you?
DOWNLOAD THE ERLEADA™ PATIENT GUIDE
ERLEADA™ is the first FDA-approved prescription medicine for men with nmCRPC. Talk to your doctor to see if it's right for you.
We’re here to help
Once your doctor decides that ERLEADA™ is right for you, Janssen CarePath can help you find the resources you may need to get started on your medication and stay on track.
Getting Started:
Janssen CarePath can review your health plan benefits and insurance coverage for ERLEADA™, and offer treatment education resources and access to nurses* who can answer your questions about ERLEADA™. We can work with your specialty pharmacy to process and deliver your medication to your home.
Staying on Track:
We understand how important it is for you to take your medication just as your doctor prescribed. Janssen CarePath provides ongoing support to help you stay on track with your ERLEADA™ treatment.
Paying for ERLEADA™:
We can identify cost support options that may help with managing your out-of-pocket costs–whether you have commercial or private insurance, government insurance such as Medicare or Medicaid, or have no insurance coverage.
*The nurse program is limited to education for patients about their Janssen therapy, its administration, and/or their disease, and is not intended to provide medical advice, replace a treatment plan from the patient's doctor or nurse, or provide case management services.
Janssen CarePath Savings Program:
If you use commercial or private health insurance:
The Janssen CarePath Savings Program provides eligible patients with instant savings on ERLEADA™ medication costs.
A MONTH†
†Up to $15,000 maximum program benefit per calendar year or one-year supply, whichever comes first. Not valid for patients using Medicare, Medicaid, or any other government-funded programs. There is no income requirement. See full eligibility requirements at www.JanssenCarePath.com
Personalized Account:
Sign up or log in to your personal Janssen CarePath Account at MyJanssenCarePath.com to check your insurance coverage; if eligible, enroll in the Janssen CarePath Savings Program; and sign up for nurse support or treatment reminders.
Sign Up For Updates
IMPORTANT SAFETY INFORMATION
Do not take ERLEADA™ (apalutamide) if you:
- are pregnant or may become pregnant. ERLEADA™ may harm your unborn baby.
- are female. ERLEADA™ is not for use in women.
Before taking ERLEADA™, tell your healthcare provider about all your medical conditions, including if you:
- have a history of seizures, brain injury, stroke, or brain tumors.
- have a partner who is pregnant or may become pregnant. Men who are sexually active with a pregnant woman must use a condom during and for 3 months after treatment with ERLEADA™. If your sexual partner may become pregnant, an effective birth control (contraception) must be used during and for 3 months after treatment. Talk with your healthcare provider if you have questions about birth control.
Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. ERLEADA™ can interact with many other medicines.
You should not start or stop any medicine before you talk with the healthcare provider that prescribed ERLEADA™.
Know the medicines you take. Keep a list of them with you to show to your healthcare provider and pharmacist when you get a new medicine.
How should I take ERLEADA™?
- Take ERLEADA™ exactly as your healthcare provider tells you.
- Take your prescribed dose of ERLEADA™ 1 time a day, at the same time each day.
- Take ERLEADA™ with or without food.
- Swallow ERLEADA™ tablets whole.
- Your healthcare provider may change your dose if needed.
- Do not stop taking your prescribed dose of ERLEADA™ without talking with your healthcare provider first.
- If you miss a dose of ERLEADA™, take your normal dose as soon as possible on the same day. Return to your normal schedule on the following day. You should not take extra tablets to make up the missed dose.
- You should start or continue a gonadotropin-releasing hormone (GnRH) analog therapy during your treatment with ERLEADA™ unless you had a surgery to lower the amount of testosterone in your body (surgical castration).
- If you take too much ERLEADA™, call your healthcare provider or go to the nearest hospital emergency room.
- Your healthcare provider may do blood tests to check for side effects.
What are the possible side effects of ERLEADA™?
ERLEADA™ may cause serious side effects including:
- Falls and fractures. ERLEADA™ treatment can cause bones and muscles to weaken and may increase your risk for falls and fractures. Falls and fractures have happened in people during treatment with ERLEADA™. Falls were not caused by loss of consciousness (fainting) or seizures. Your healthcare provider will monitor your risks for falls and fractures during treatment with ERLEADA™.
- Seizure. If you take ERLEADA™, you may be at risk of having a seizure. You should avoid activities where a sudden loss of consciousness could cause serious harm to yourself or others. Tell your healthcare provider right away if you have a loss of consciousness or seizure. Your healthcare provider will stop ERLEADA™ if you have a seizure during treatment.
The most common side effects of ERLEADA™ include:
- feeling very tired
- high blood pressure
- rash
- diarrhea
- nausea
- decreased appetite
- weight loss
- joint pain
- fall
- hot flash
- bone injury (fracture)
- swollen hands, ankles, or feet
ERLEADA™ may cause fertility problems in males, which may affect the ability to father children. Talk to your healthcare provider if you have concerns about fertility. Do not donate sperm during treatment with ERLEADA™ and for 3 months after the last dose of ERLEADA™.
Tell your healthcare provider if you have any side effect that bothers you or that does not go away.
These are not all the possible side effects of ERLEADA™.
Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
Please see the full Prescribing Information for ERLEADA™.
INDICATION
What is ERLEADA™?
ERLEADA™ is a prescription medicine used to treat prostate cancer that has not spread to other parts of the body and no longer responds to a medical or surgical treatment that lowers testosterone.
It is not known if ERLEADA™ is safe or effective in children.